Skip to main content
eScholarship
Open Access Publications from the University of California

Morphea secondary to interferon beta1b injection: a case and review of the literature

  • Author(s): Ozlu, Emin
  • Karadag, Ayse Serap
  • Akdeniz, Necmettin
  • Uzuncakmak, Tugba Kevser
  • Zemheri, Ebru
  • Ozkanli, Seyma
  • et al.
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License
Abstract

Interferon beta (IFNβ) is a drug used successfully in the treatment of multiple sclerosis (MS). Although IFNβ is a safe and well-tolerated drug, dermatological side effects are common. The most common dermatological adverse effect is a local reaction at the injection site. It may also cause inflammatory and immune-mediated dermatological side effects. However, morphea induced by IFNβ1b injection is very rare

Main Content
Current View